Comparison of two laboratory methods for the determination of serum resistance in Borrelia burgdorferi isolates

Immunobiology

Volumn 201, Issue 3-4, 2000, Pages 406-419

  Kraiczy, Peter ^a   Hunfeld, Klaus Peter ^a   Breitner Ruddock, Susanne ^b   Würzner, Reinhard ^d   Acker, Georg ^c   Brade, Volker ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

^c UNIVERSITY OF BAYREUTH   (Germany)

^d UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C9;

ARTICLE; BACTERIUM ISOLATE; BORRELIA BURGDORFERI; GROWTH INHIBITION; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE TEST; INTERMETHOD COMPARISON; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0033951138     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(00)80094-7     Document Type: Article

References (24)

1. STEERE, A. C. 1989. Lyme disease. N. Engl. J. Med. 321: 586.
2. BRADE, V., I. KLEBER, and G. ACKER. 1992. Differences of two Borrelia burgdorferi strains in complement activation and serum resistance. Immunobiol. 185: 453.
3. BREITNER-RUDDOCK, S., R. WÜRZNER, J. SCHULZE, and V. BRADE. 1997. Heterogeneity in the complement-dependent bacteriolysis within the species of Borrelia burgdorferi. Med. Microbiol. Immunol. 185: 253.
4. VAN DAM, A. P., A. OEI, R. JASPARS, C. FIJEN, B. WILSKE, L. SPANJAARD, and J. DANKERT. 1997. Complement-mediated serum sensitivity among spirochetes that cause Lyme disease. Infect Immun. 65: 1228.
5. BELFAIZA, J., D. POSTIC, E. BELLENGER, G. BARANTON, and I. SAINT-GIRONS. 1993. Genomic fingerprinting of Borrelia burgdorferi sensu lato by pulsed-field gel electrophoresis. J. Clin. Microbiol. 31: 2873.
6. WÜRZNER, R., M. SCHULZE, L. HAPPE, A. FRANZKE, F. A. BIEBER, M. OPPERMANN, and O. GÖTZE. 1991. Inhibition of terminal complement complex formation and cell lysis by monoclonal antibodies. Complem. Inflam. 8: 328.
7. WÜRZNER, R., H. XU, A. FRANZKE, M. SCHULZE, J. H. PETERS, and O. GÖTZE. 1991. Blood dentritic cells carry terminal complement complexes on their cell surface as detected by newly developed neoepitope-specific monoclonal antibodies. Immunol. 74: 132.
8. VALENTINE, R. C., B. M. SHAPIRO, and E. R. STADTMAN. 1968. Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Eschrichia coli. Biochem. 7: 2143.
9. TRAUB, W. H., G. ACKER, and I. KLEBER. 1976. Ultrastructural surface alteration of Serratia marcescens after exposure to polymycin and/or fresh human serum. Chemotherapy 22: 104.
10. SPURR, A. R. 1969. A low-viscosity epoxy resin embedding medium for electron microscopy. J. Ultrastruct. Res. 26: 31.
11. REYNOLDS, E. S. 1963. The use of lead citrate at high pH as an electron opaque stain in electron microscopy. L. Cell. Biol. 7: 208.
12. WILSKE, B., V. PREAC-MURSIC, U. B. GÖBEL, B. GRAF, S. JAURIS, E. SOUTSCHEK, E. SCHWAB, and G. ZUMSTEIN. 1993. An OspA serotyping system for Borrelia. burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. J. Clin. Microbiol. 31: 340.
13. KOCHI, S. K., R. C. JOHNSON, and A. P. DALMASSO. 1991. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex. J. Immunol. 146: 3964.
14. KURTENBACH, K., H. S. SEWELL, N. H. OGDEN, S. E. RANDOLPH, and P. A. NUTTALL. 1998. Serum complement sensitivity as a key factor in Lyme disease ecology. Infect. Immun. 66: 1248.
15. KOCHI, S. K. and R. C. JOHNSON. 1988. Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway. Infect. Immun. 56: 314.
16. SHAFER, W. M., K. JOINER, L. F. GUYMAN, M. S. COHEN, and P. F. SPARLING. 1984. Serum sensitivity of Neisseria gonorrhoeae: the role of lipopolysaccharide. J. Infect. Dis. 149: 175.
17. THOMÁS, J. M., B. CIURANA, V. J. BENEDÍ, and A. JUAREZ. 1988. Role of lipopolysaccharide and complement susceptibility of Escherichia coli and Salmonella typhimurium to nonimmune serum. J. Gen. Microbiol. 134: 1009.
18. CIURANA, B. and J. M. TOMÁS. 1987. Role of lipopolysaccharide and complement susceptibility of Klebsiella pneumoniae to nonimmune serum. Infect. Immun. 55: 2741.
19. BECK, G., G. S. HABICHT, J. L. BENACH, and J. L. COLEMAN. 1987. Chemical and biological characterization of a lipopolysaccharide extracted from the Lyme disease spirochete (Borrelia burgdorferi). J. Infect. Dis. 152: 108.
20. SADZIENE, A., A. G. BARBOUR, P. A. ROSA, and D. D. THOMAS. 1993. An OspB mutant of Borrelia burgdorferi has reduced invasiveness in vitro and reduced infectivity in vivo. Infect. Immun. 61: 3390.
21. SADZIENE, A., D. D. THOMAS, and A. G. BARBOUR. 1995. Borrelia burgdorferi mutant lacking Osp: biological and immunological characterization. Infect. Immun. 63: 1573.
22. OHLENBUSCH, A., F. R. MATUSCHKA, D. RICHTER, H. J. CHRISTEN, R. THOMSON, A. SPIELMAN, and H. EIFFERT. 1996. Etiology of the acrodermatitis atrophicans lesion in Lyme disease. J. Infect. Dis. 174: 421.
23. VAN DAM, A. P., H. KUIPER, K. VOS, A. WIDJOJOKUSUMO, L. SPANJAARD, B. M. DE JONGH, A. C. P. RAMSELAAR, M. D. KRAMER, and J. DANKERT. 1997. Difference genospecies of B. burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin. Infect. Dis. 17: 708.
24. ACKER, G. 1998. Immunoelectron microscopy of surface antigens (polysaccharides) of gram-negative bacteria using pre- and post-embedding techniques. Methods Microbiol. 20: 147.